Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Samsung Medical Center Opens Proton Therapy Facility

By HospiMedica International staff writers
Posted on 13 Jun 2016
Samsung Medical Center (SMC; Seoul, South Korea) has opened a new proton therapy facility for cancer treatment, equipped with a cyclotron and two rotating gantries.

The SMC proton therapy facility will provide two different irradiation nozzle systems, including a multi-purpose nozzle in the first treatment room that can offer both conventional broad beam irradiation and advanced pencil beam scanning (PBS); irradiation modes can be switched on demand, depending on the target diseases. More...
The second treatment room provides a dedicated scanning nozzle that offers PBS for larger fields (maximum 40x30 cm). A future, third treatment room is planned with a rotating gantry.

PBS delivers narrow proton beams to the targeted cancer tissue conforming to the shape of tumor, enabling complex tumors to be irradiated precisely with concentrated high doses, while minimizing side effects for surrounding healthy tissues. In comparison with broad beam irradiation, preparation prior to treatment is easier, and the consumable cost for patient’s specific compensators and collimators can be decreased by PBS. The broad beam treatment room (G1) opened in December 2015, and the large field PBS treatment room (G2) was launched in March 2016.

“Proton therapy is a state of the art radiation therapy which can increase the cure rate, while minimizing the normal tissue toxicity,” said Professor Youngyih Han, PhD, project manager of the SMC proton project. “Therefore, facilities introducing proton therapy have been ramped up all over the world and the demand is expected to grow. On the other hand, further technical research and development and professional human resource development for proton therapy is essential.”

SMC is one of the leading hospitals in Korea, with almost 2,000 patient beds, a staff of 8,000, and over 150,000 patients treated annually. It is composed of Samsung Seoul Hospital Kangbook Samsung Hospital, Samsung Changwon hospital, and the Samsung Life Sciences Research Center. SMC was founded in 1994 under the philosophy of “contributing to improving the nation’s health through the best medical service, advanced medical research, and development of outstanding medical personnel.”

Related Links:
Samsung Medical Center


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.